221 related articles for article (PubMed ID: 15810508)
21. CXCL16 is a marker of inflammation, atherosclerosis, and acute coronary syndromes in humans.
Lehrke M; Millington SC; Lefterova M; Cumaranatunge RG; Szapary P; Wilensky R; Rader DJ; Lazar MA; Reilly MP
J Am Coll Cardiol; 2007 Jan; 49(4):442-9. PubMed ID: 17258089
[TBL] [Abstract][Full Text] [Related]
22. Inflammatory biomarkers in stable atherosclerosis.
Kinlay S; Egido J
Am J Cardiol; 2006 Dec; 98(11A):2P-8P. PubMed ID: 17126676
[TBL] [Abstract][Full Text] [Related]
23. The role of inflammation in coronary artery calcification.
Li JJ; Zhu CG; Yu B; Liu YX; Yu MY
Ageing Res Rev; 2007 Dec; 6(4):263-70. PubMed ID: 17964226
[TBL] [Abstract][Full Text] [Related]
24. Local release of C-reactive protein from vulnerable plaque or coronary arterial wall injured by stenting.
Inoue T; Kato T; Uchida T; Sakuma M; Nakajima A; Shibazaki M; Imoto Y; Saito M; Hashimoto S; Hikichi Y; Node K
J Am Coll Cardiol; 2005 Jul; 46(2):239-45. PubMed ID: 16022949
[TBL] [Abstract][Full Text] [Related]
25. Mayo Clinic office visit. Testing C-reactive protein. An interview with Thomas Behrenbeck, M.D., Ph.D.
Behrenbeck T
Mayo Clin Womens Healthsource; 2010 Feb; 14(2):6. PubMed ID: 20048728
[No Abstract] [Full Text] [Related]
26. Evidence of systemic inflammation and estimation of coronary artery disease risk: a population perspective.
Wilson PW
Am J Med; 2008 Oct; 121(10 Suppl 1):S15-20. PubMed ID: 18926165
[TBL] [Abstract][Full Text] [Related]
27. Increased plasma C-reactive protein and interleukin-6 concentrations in patients with slow coronary flow.
Li JJ; Qin XW; Li ZC; Zeng HS; Gao Z; Xu B; Zhang CY; Li J
Clin Chim Acta; 2007 Oct; 385(1-2):43-7. PubMed ID: 17706955
[TBL] [Abstract][Full Text] [Related]
28. Value of CRP in coronary risk determination.
Mehta JL; Sukhija R; Romeo F; Sepulveda JL
Indian Heart J; 2007; 59(2):173-7. PubMed ID: 19122252
[TBL] [Abstract][Full Text] [Related]
29. Risk factor analysis of plasma cytokines in patients with coronary artery disease by a multiplexed fluorescent immunoassay.
Martins TB; Anderson JL; Muhlestein JB; Horne BD; Carlquist JF; Roberts WL; Carlquist JF
Am J Clin Pathol; 2006 Jun; 125(6):906-13. PubMed ID: 16690490
[TBL] [Abstract][Full Text] [Related]
30. Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization.
Dahl TB; Yndestad A; Skjelland M; Øie E; Dahl A; Michelsen A; Damås JK; Tunheim SH; Ueland T; Smith C; Bendz B; Tonstad S; Gullestad L; Frøland SS; Krohg-Sørensen K; Russell D; Aukrust P; Halvorsen B
Circulation; 2007 Feb; 115(8):972-80. PubMed ID: 17283255
[TBL] [Abstract][Full Text] [Related]
31. [Inflammation and C-reactive protein in cardiovascular disease].
Munk PS; Larsen AI
Tidsskr Nor Laegeforen; 2009 Jun; 129(12):1221-4. PubMed ID: 19521445
[TBL] [Abstract][Full Text] [Related]
32. Inflammatory markers in coronary artery disease.
Ikonomidis I; Michalakeas CA; Parissis J; Paraskevaidis I; Ntai K; Papadakis I; Anastasiou-Nana M; Lekakis J
Biofactors; 2012; 38(5):320-8. PubMed ID: 22628054
[TBL] [Abstract][Full Text] [Related]
33. [Etiopathogenesis of atherosclerosis--a clinical problem that is still relevant].
Mizerska M; Goch JH
Pol Merkur Lekarski; 2006 Feb; 20(116):133-8. PubMed ID: 16708625
[TBL] [Abstract][Full Text] [Related]
34. [Inflammation and plaque instability].
Malpartida F; Vivancos R; Urbano C; Mora J
Arch Cardiol Mex; 2007; 77 Suppl 4():S4-16-22. PubMed ID: 18938692
[TBL] [Abstract][Full Text] [Related]
35. Chemokines and cardiovascular risk.
Aukrust P; Halvorsen B; Yndestad A; Ueland T; Øie E; Otterdal K; Gullestad L; Damås JK
Arterioscler Thromb Vasc Biol; 2008 Nov; 28(11):1909-19. PubMed ID: 18669888
[TBL] [Abstract][Full Text] [Related]
36. [C-reactive protein in coronary disease--pathogenic factor or marker of the disease].
Goch JH; Sadurska J
Pol Merkur Lekarski; 2002 Jul; 13(73):70-3. PubMed ID: 12362513
[TBL] [Abstract][Full Text] [Related]
37. High sensitive C-reactive protein: a novel biochemical markers and its role in coronary artery disease.
Mitra B; Panja M
J Assoc Physicians India; 2005 Jan; 53():25-32. PubMed ID: 15857009
[TBL] [Abstract][Full Text] [Related]
38. Chemokines in cardiovascular risk prediction.
Aukrust P; Yndestad A; Smith C; Ueland T; Gullestad L; Damås JK
Thromb Haemost; 2007 May; 97(5):748-54. PubMed ID: 17479185
[TBL] [Abstract][Full Text] [Related]
39. Atherosclerosis: an inflammatory disease.
Liuzzo G
Rays; 2001; 26(4):221-30. PubMed ID: 12696277
[TBL] [Abstract][Full Text] [Related]
40. HMGB1 expression by activated vascular smooth muscle cells in advanced human atherosclerosis plaques.
Inoue K; Kawahara K; Biswas KK; Ando K; Mitsudo K; Nobuyoshi M; Maruyama I
Cardiovasc Pathol; 2007; 16(3):136-43. PubMed ID: 17502242
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
